Skip to main content
Valneva SE logo

Valneva SE — Investor Relations & Filings

Ticker · VLA ISIN · FR0004056851 LEI · 969500DIVIP5VKNW4948 PA Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2025-06-04 AGM Information
Country FR France
Listing PA VLA

About Valneva SE

https://valneva.com/

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.

Recent filings

Filing Released Lang Actions
Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction
AGM Information Classification · 95% confidence The document is a press release from Valneva SE dated June 4, 2025. The headline explicitly states two main topics: 'Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte' (Valneva announces the availability of preparatory documents for its Combined General Meeting) and 'une évolution de son équipe de direction' (a change in its management team). 1. The first part concerns the upcoming Annual General Meeting (AGM) on June 25, 2025, and the availability of related preparatory documents (agenda, resolutions, etc.). This strongly points towards AGM-related material. 2. The second part announces the departure of a co-founder and Chief Business Officer, which is a change in senior management. Given the dual nature, we must select the most fitting primary category. The document is primarily an announcement regarding the AGM logistics and documentation availability, which is a key component of AGM preparation. The management change is secondary information included in the same release. The category 'AGM-R' (AGM Information) covers presentations and materials shared during the AGM, and this announcement serves as the official notice and availability point for those materials. While 'MANG' (Board/Management Information) is relevant for the departure, the primary focus and the most detailed section relate to the General Meeting documents. Since this is an announcement about the preparatory documents for the AGM, AGM-R is the most appropriate classification, as it relates directly to the meeting itself, which is the central corporate event being discussed.
2025-06-04 French
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
AGM Information Classification · 98% confidence The document is titled 'Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update'. It explicitly mentions the 'Combined General Meeting' ('the Meeting') scheduled for June 25, 2025, and states that the documentation (agenda, draft resolutions) is now available. This announcement concerns the materials and logistics for a shareholder meeting, which aligns directly with the purpose of an AGM-related filing. While it announces the availability of documentation, the core subject is the AGM itself, making AGM-R (AGM Information) the most specific fit, rather than just RPA (Report Publication Announcement), as it details the meeting logistics and includes a corporate update (management departure). Since the primary focus is the meeting documentation and logistics, AGM-R is appropriate.
2025-06-04 English
6-K
Regulatory Filings
2025-05-27 English
Valneva participera à différentes conférences d’investisseurs aux États-Unis et en Europe au cours du mois de juin
Regulatory Filings Classification · 99% confidence The document is a press release dated May 26, 2025, announcing that members of Valneva's management team will be participating in various investor conferences in the US and Europe during June 2025. It lists specific conferences (Jefferies Global Healthcare Conference, Goldman Sachs 46th Annual Global Healthcare Conference, Oddo BHF Nextcap Forum, BNP Paribas SMID Cap Conference) where management will conduct presentations and investor meetings. This type of announcement, detailing management's schedule for meeting with investors at external industry events, is characteristic of an Investor Presentation or related communication, but since the core purpose is to inform about upcoming meetings and discussions about strategy/pipeline (VLA15, commercial vaccines), it aligns best with the intent of an Investor Presentation (IP) or a general announcement about investor engagement. Given the options, 'Investor Presentation' (IP) is the closest fit for an announcement detailing management's schedule for investor engagement at industry conferences, although 'Report Publication Announcement' (RPA) could also be considered if it were just announcing the *release* of a document. However, this document *is* the announcement about the meetings themselves, which is a common precursor/component of investor relations activity. Since it details the schedule for management meetings and presentations at external conferences, it falls under the scope of Investor Relations materials, making IP the most appropriate classification over a generic RPA or RNS.
2025-05-26 French
Valneva to Participate at U.S. and European Investor Conferences in June
Regulatory Filings Classification · 99% confidence The document is a press release dated May 26, 2025, announcing that Valneva's senior management will present and hold investor meetings at several upcoming investor conferences in June 2025 (Jefferies, Goldman Sachs, Oddo BHF, BNP Paribas). This type of announcement, which details management's schedule for engaging with investors at external events, is characteristic of an Investor Presentation or general investor relations activity announcement, but it is not the presentation itself, nor is it a formal regulatory filing like a 10-K or ER. Since the content is specifically about management's schedule for investor engagement and discussions about the pipeline (VLA15, etc.), it aligns best with materials related to investor outreach. Among the provided codes, 'IP' (Investor Presentation) is the closest fit for content focused on presenting company strategy and pipeline to investors, even though this specific document is an announcement *about* those presentations rather than the presentation slides themselves. However, given the options, and recognizing that this is a proactive communication aimed at investors regarding future engagement, it is most closely related to investor relations activities. If 'RPA' (Report Publication Announcement) were used, it would typically announce the release of a formal report (like an Annual Report or Earnings Release). Since this announces participation in investor conferences, 'IP' (Investor Presentation) is the most contextually relevant category for the *subject matter* being discussed, although 'RPA' or 'RNS' could be argued if strictly interpreting the 'announcement' nature. Given the focus on management meetings and presentations at investor conferences, 'IP' is selected as the primary classification for the subject matter being promoted.
2025-05-26 English
6-K
Regulatory Filings
2025-05-12 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.